Advances in dual-targeting inhibitors of HDAC6 for cancer treatment

Gu, Zhicheng; Lin, Shuxian; Yu, Junhui; Jin, Fei; Zhang, Qingqing; Xia, Keli; Chen, Lei; Li, Yan; He, Bin

doi:10.1016/j.ejmech.2024.116571

European Journal of Medicinal Chemistry

2024

DOI: 10.1016/j.ejmech.2024.116571

|View full text |Cite

Advances in dual-targeting inhibitors of HDAC6 for cancer treatment

Zhicheng Gu,

Shuxian Lin,

Junhui Yu

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 194 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

HDAC6 mediates tumorigenesis during mitosis and the development of targeted deactivating agents

Peng,

Liu,

Liu

et al. 2024

Bioorganic Chemistry

View full text Add to dashboard Cite

HDAC6 mediates tumorigenesis during mitosis and the development of targeted deactivating agents

Peng,

Liu,

Liu

et al. 2024

Bioorganic Chemistry

View full text Add to dashboard Cite

Small molecules targeting HDAC6 for cancer treatment: Current progress and novel strategies

Huang,

Li,

Cheng

et al. 2024

Biomedicine & Pharmacotherapy

View full text Add to dashboard Cite

Expression patterns of HDAC6 in correlation to ARID1A status in different subtypes of endometriosis: A retrospective tissue microarray analysis

Zingg,

Kalaitzopoulos,

Karol

et al. 2024

European Journal of Obstetrics & Gynecology and Reproductiv

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Advances in dual-targeting inhibitors of HDAC6 for cancer treatment

Cited by 3 publications

References 194 publications

HDAC6 mediates tumorigenesis during mitosis and the development of targeted deactivating agents

HDAC6 mediates tumorigenesis during mitosis and the development of targeted deactivating agents

Small molecules targeting HDAC6 for cancer treatment: Current progress and novel strategies

Expression patterns of HDAC6 in correlation to ARID1A status in different subtypes of endometriosis: A retrospective tissue microarray analysis

Contact Info

Product

Resources

About